These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17389510)

  • 1. Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration.
    Zuluaga MF; Mailhos C; Robinson G; Shima DT; Gurny R; Lange N
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1767-72. PubMed ID: 17389510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV.
    Lange N; Ballini JP; Wagnieres G; van den Bergh H
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):38-46. PubMed ID: 11133846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
    Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A
    Retina; 2006; 26(9):988-93. PubMed ID: 17151484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R; Gabric N
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Nowak-Sliwinska P; van den Bergh H; Sickenberg M; Koh AH
    Prog Retin Eye Res; 2013 Nov; 37():182-99. PubMed ID: 24140257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone.
    Augustin AJ; Puls S; Offermann I
    Retina; 2007 Feb; 27(2):133-40. PubMed ID: 17290193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
    Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
    Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
    Tamaki Y
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.
    Kourlas H; Abrams P
    Clin Ther; 2007 Sep; 29(9):1850-61. PubMed ID: 18035187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.
    Tatar O; Adam A; Shinoda K; Stalmans P; Eckardt C; Lüke M; Bartz-Schmidt KU; Grisanti S
    Am J Ophthalmol; 2006 Jul; 142(1):95-104. PubMed ID: 16815256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy for age-related macular degeneration.
    Jin C; Ge J; Zhou S; Chen H; Zhong X; Jiang R; Chen L; Chen L
    Yan Ke Xue Bao; 2004 Sep; 20(3):158-62. PubMed ID: 15499723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.
    Bashshur ZF; Schakal A; Hamam RN; El Haibi CP; Jaafar RF; Noureddin BN
    Arch Ophthalmol; 2007 Oct; 125(10):1357-61. PubMed ID: 17923543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration.
    Samkoe KS; Clancy AA; Karotki A; Wilson BC; Cramb DT
    J Biomed Opt; 2007; 12(3):034025. PubMed ID: 17614733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
    Husain D; Kramer M; Kenny AG; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM; Lai S; Markey CM
    Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early effects of triamcinolone on vascular endothelial growth factor and endostatin in human choroidal neovascularization.
    Tatar O; Shinoda K; Kaiserling E; Pertile G; Eckardt C; Mohr A; Yoeruek E; Szurman P; Bartz-Schmidt KU; Grisanti S
    Arch Ophthalmol; 2008 Feb; 126(2):193-9. PubMed ID: 18268209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.